FDA daily for Saturday, October 3, 2026
In this issue: 8 shortage updates. 1 item touches categories MedGrid carries, and it comes first.
For MedGrid's categories
Items in this issue that name a product category sold on MedGrid. Each links to its full FDA record; the chip opens that category's federal and state rules.
- Azacitidine Injection
Bristol Myers Squibb Co. · Available
Drug shortages
FDA date:FDA updated 8 shortage entries on Fri, Oct 2: 8 status updates.
- Azacitidine Injection
Bristol Myers Squibb Co. · Available
- Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet
Elite Laboratories, Inc. · Available
- Lisdexamfetamine Dimesylate Capsule
Alvogen · Available
- Lisdexamfetamine Dimesylate Capsule
Elite Laboratories, Inc. · Limited Availability · Reason: Shortage of an active ingredient
- Clonazepam Tablet
Cheplapharm Arzneimittel GmbH · Available
- Dexmedetomidine Hydrochloride Injection
Par Health, USA LLC · Unavailable · Reason: Other
- Methylprednisolone Acetate Injection
Par Health, USA LLC · Unavailable · Reason: Other
FDA did not answer for Drug recalls, Device recalls, Food and supplement recalls, Labels, Clearances, Approvals while this issue was written; those sections will fill in on a later visit.
How the FDA daily is written
Every issue is written from FDA's public data (openFDA) and nothing else: the counts, names, firms and reasons are FDA's own. openFDA posts each kind of record on its own delay, so each section covers one FDA date and says which. Shortages cover yesterday; approvals, drug and device recalls, and food and supplement recalls cover a week ago; device clearances and label changes cover two weeks ago. Every FDA date appears in exactly one issue. Complete response letters appear the day after FDA publishes a batch.
Subscribe with any feed reader, or point an email tool at the RSS feed to send each issue as a newsletter. Search any drug, device or company across every FDA dataset in the FDA data explorer.